Journal of Multiple Sclerosis and Neuroimmunology

Search

Page Path

HOME
Search

Original Article

Tolerability of Interferon Beta-1b for Multiple Sclerosis and Clinically Isolated Syndrome in Korea: YooHwan Kim, Byung-Jo Kim, Byoung Joon Kim, Jeeyoung Oh, In Soo Joo, Young-Min Lim, Yoen Jung Lee, Kwang-Kuk Kim; J Mult Scler Neuroimmunol. 2015;6(2):29-36. Published online September 1, 2015; PDF

Volume 17, No. 1

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

6,288	Autoimmune Nodopathy: When to Suspect and How to Treat?
5,414	National Consensus Guidance for Management of Refractory Myasthenia Gravis
4,034	The Clinical Utility of the Ocrelizumab for the Patients with Multiple Sclerorsis
3,095	Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder
2,939	Collaboration between Medical Association and Patient Organizations to Overcome Rare Neurological Disorders

Cited By 3	National Consensus Guidance for Management of Refractory Myasthenia Gravis
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis
Cited By 1	Collaboration between Medical Association and Patient Organizations to Overcome Rare Neurological Disorders
Cited By 1	Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2026 by Korean Society of Neuroimmunology.